The 2026 Giro d’Italia has lost another marquee general classification rider. EF Education-EasyPost confirmed on April 29 that 2019 Giro champion Richard Carapaz will not start the race in Sofia next month, with the Ecuadorian still recovering from surgery to remove a perineal cyst.
The decision marks a significant blow to the GC fight, coming after João Almeida (UAE Team Emirates XRG) and Mikel Landa (Soudal Quick-Step) were also ruled out — leaving the Italian Grand Tour stripped of three of the most credentialed climbers in the peloton.
What Happened
Carapaz, 32, underwent surgery earlier in April to remove a perineal cyst that had been compromising his ability to ride. EF Education-EasyPost initially insisted his Giro participation was not at risk, but the team’s chief medical officer has now confirmed that the surgical wound was larger than expected, and the recovery window has run beyond what is realistic for a three-week Grand Tour.
“Rather than have him start the Giro at less than 100% and risk further complications, we have decided it is more prudent to prepare him properly for the Tour de France,” EF said in its official statement. Carapaz is now expected to pivot his entire spring around July, where he will lead EF’s GC ambitions in France.
The Olympic road race champion finished third overall at the 2025 Giro d’Italia and won the race outright in 2019, making him one of only a handful of active riders with a Maglia Rosa on his palmarès. He had been entered as EF’s protected leader for Italy.
Why It Matters
Carapaz is the third high-profile GC contender to drop out of the 2026 Giro d’Italia, which will be the first edition of the race ever to start outside Italy in Sofia, Bulgaria. The exits of Almeida and Landa already gutted the climber-heavy GC field; losing Carapaz tilts it even further toward Jonas Vingegaard, who arrives off a dominant Volta a Catalunya and is widely tipped to attempt the historic Giro-Tour double.
Without Almeida, Landa, or Carapaz to push him on the brutal mountain stages, Vingegaard’s main threats are likely to come from Primož Roglič, Antonio Tiberi and a young, ascending generation led by Paul Seixas. The Visma–Lease a Bike rider’s path to a third Grand Tour title — and a real shot at becoming the first man since Marco Pantani in 1998 to win Giro and Tour in the same year — has been smoothed considerably.
For EF Education-EasyPost, the impact cuts the other way. The American team has built much of its 2026 Grand Tour season around Carapaz’s early peak. With the Giro now out of reach, expect EF to invest heavily in supporting his Tour de France preparation through altitude blocks at Sierra Nevada, the Critérium du Dauphiné, and the Tour de Suisse — the same buildup pattern that delivered him to the Giro podium last May.
A Pattern of GC Withdrawals
The 2026 Giro now has a curious profile: a route designed to favor pure climbers — including the €15 million infrastructure investment in the queen mountain stage — but a startlist missing many of the climbers it was built for.
- João Almeida (UAE Team Emirates XRG): Withdrew after a knee injury sustained training in late March; will refocus on the Tour de France in support of Tadej Pogačar.
- Mikel Landa (Soudal Quick-Step): Pulled from Giro selection after illness in his Vuelta al País Vasco buildup; targets Vuelta a España.
- Richard Carapaz (EF Education-EasyPost): Out due to extended cyst-surgery recovery; pivots to Tour de France leadership.
That triple withdrawal opens the door for outsider GC threats — riders like Geraint Thomas, Antonio Tiberi, and Egan Bernal, who is currently rebuilding his racing legs at the Tour of the Alps ahead of his own Tour de France campaign. Several of these riders had penciled in the Giro as a stage-hunting affair; they may now have legitimate podium opportunities.
What This Means For You
If you’ve been planning to follow the 2026 Giro as a Carapaz vs. Vingegaard duel, recalibrate. The race is now Vingegaard’s to lose on paper — but Grand Tours rarely go to script, and the Bulgarian opening week followed by a sprint-heavy first half could create three-plus minutes of GC time gaps before the mountains even arrive.
For amateur riders watching the GC story unfold, Carapaz’s decision is also a useful reminder of how fragile peak fitness windows are at the highest level. Coming back from surgery within four to six weeks is theoretically possible — but coming back to the volume and intensity required to contest a three-week Grand Tour is a different proposition entirely. EF’s medical team made the call to protect his July rather than gamble on May, and that’s a calculation every cyclist returning from injury should respect: rushing back too early often costs more than waiting.
Key Takeaways
- Richard Carapaz officially withdraws from the 2026 Giro d’Italia, confirmed by EF Education-EasyPost on April 29.
- The 2019 champion and 2025 podium finisher will refocus on the Tour de France after extended recovery from cyst surgery.
- Carapaz joins João Almeida and Mikel Landa on the list of major GC contenders missing the race.
- Jonas Vingegaard is now the overwhelming GC favorite for the 2026 Giro, with the Giro-Tour double increasingly viable.
- The depleted field opens podium opportunities for second-tier GC names including Tiberi, Thomas, and the young Paul Seixas.
The 2026 Giro d’Italia begins with a three-stage Bulgarian Grande Partenza on May 8, before transferring back to Italy for the bulk of the race. Stage 1 is a 187-kilometer route from Sofia to Plovdiv, expected to favor the sprinters before the GC contenders go on the offensive in the second week.
Looking for more pro cycling coverage? Read our recap of Tadej Pogačar’s record-tying fourth Liège-Bastogne-Liège, our preview of La Vuelta Femenina 2026, and our profile of breakout 19-year-old GC star Paul Seixas.
